We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

140 hedge funds and large institutions have $823M invested in NEVRO CORP. in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 51 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

17% more capital invested

Capital invested by funds: $702M → $823M (+$122M)

3% more funds holding

Funds holding: 136140 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 51

32% less call options, than puts

Call options by funds: $14.3M | Put options by funds: $21M

Holders
140
Holders Change
+4
Holders Change %
+2.94%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
22
Increased
48
Reduced
51
Closed
17
Calls
$14.3M
Puts
$21M
Net Calls
-$6.66M
Net Calls Change
-$6.49M

NVRO Hedge Fund Activity: Q4 2023 in Review

140 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2023, worth a combined $823M — up 17% from $702M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NVRO positions and 17 closed out — a net gain of 5 holders — while 48 added to existing stakes and 51 trimmed.

The largest buyer was Engaged Capital, opening a new position worth an estimated $38.7M. The largest seller was Norges Bank, cutting an estimated $22.9M.

  • 140 institutional investors held NEVRO CORP. (NVRO) as of Q4 2023, up from 136 in Q3 2023.
  • Funds reported $823M of NEVRO CORP. stock for Q4 2023, up 17% quarter-over-quarter.
  • 22 funds opened new NEVRO CORP. positions in Q4 2023 and 17 closed out, a net change of +5 holders.
  • The largest NEVRO CORP. buyer in Q4 2023 was Engaged Capital, an estimated $38.7M added.
  • The largest NEVRO CORP. seller in Q4 2023 was Norges Bank, an estimated $22.9M sold.

Based on aggregated 13F filings for Q4 2023.